Haru Morita
Founder at MODALIS THERAPEUTICS CORPORATION
Net worth: 3 M $ as of 30/04/2024
Haru Morita active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MODALIS THERAPEUTICS CORPORATION | Director/Board Member | 01/01/2016 | - |
| Chief Executive Officer | 01/01/2016 | - | |
| Founder | 01/01/2016 | - | |
| President | 01/01/2016 | - | |
| Modalis Therapeutics, Inc. | Chief Executive Officer | 01/04/2016 | - |
Career history of Haru Morita
Former positions of Haru Morita
| Companies | Position | Start | End |
|---|---|---|---|
REGiMMUNE Corp.
 REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Chief Executive Officer | 01/03/2006 | - |
| Chairman | 01/03/2006 | - | |
| Founder | 01/03/2006 | - | |
| President | 01/03/2006 | - | |
Booz Allen Hamilton International (U.K.) Ltd.
 Booz Allen Hamilton International (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Booz Allen & Hamilton International provides management and technology consulting services. The company provides services to international corporations and governments around the world. It was founded in 1914 and is located in McLean, VA. | Corporate Officer/Principal | - | - |
Kirin Brewery Co. Ltd.
 Kirin Brewery Co. Ltd. Beverages: AlcoholicConsumer Non-Durables Kirin Brewery Co., Ltd. engages in the manufacture of alcoholic beverages. Its products include beer, sparkling liquor, chuhai, gin, and whiskey. The company was founded in 1901 and is headquartered in Tokyo, Japan. | Chief Tech/Sci/R&D Officer | 15/07/2009 | - |
| Corporate Officer/Principal | - | 15/07/2009 | |
Y's Therapeutics, Inc.
 Y's Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Y's Therapeutics, Inc. manufactures biopharmaceuticals. | Corporate Officer/Principal | - | - |
Training of Haru Morita
| School of Engineering, The University of Tokyo | Graduate Degree |
Statistics
International
| Japan | 5 |
| United States | 3 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 3 |
| Founder | 2 |
Sectoral
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Non-Durables | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MODALIS THERAPEUTICS CORPORATION | Health Technology |
| Private companies | 5 |
|---|---|
Y's Therapeutics, Inc.
Y's Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Y's Therapeutics, Inc. manufactures biopharmaceuticals. | Health Technology |
Booz Allen Hamilton International (U.K.) Ltd.
Booz Allen Hamilton International (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Booz Allen & Hamilton International provides management and technology consulting services. The company provides services to international corporations and governments around the world. It was founded in 1914 and is located in McLean, VA. | Commercial Services |
Kirin Brewery Co. Ltd.
Kirin Brewery Co. Ltd. Beverages: AlcoholicConsumer Non-Durables Kirin Brewery Co., Ltd. engages in the manufacture of alcoholic beverages. Its products include beer, sparkling liquor, chuhai, gin, and whiskey. The company was founded in 1901 and is headquartered in Tokyo, Japan. | Consumer Non-Durables |
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Health Technology |
| Modalis Therapeutics, Inc. |
- Stock Market
- Insiders
- Haru Morita
- Experience
